NHS Left Shift Part 2: The NHS doesn’t have a demand problem – but it does have a placement problem
Demand in the NHS is often described as “unmanageable”, but that’s not quite right.
What the NHS actually has is demand showing up in the wrong place at the wrong time, delivered by the most expensive workforce in the least flexible settings.
Hospitals are full of activity that is clinically appropriate but operationally inefficient and financially unsustainable.
Low complexity, high volume outpatient activity consumes consultant time, clinic rooms, admin capacity and diagnostic slots. Much of it runs at or below marginal cost once true overheads are applied.
This is the uncomfortable truth many Trust Boards don’t articulate openly, turnover does not equal profit and activity does not equal value.
Why does “left shift” makes NHS leaders nervous?
On paper, left shifting care out of hospital makes sense. In practice it often triggers fear because when Trust leaders are told: “We want to move activity out of hospital,” they instinctively hear, “we are about to lose income, staff and control.”
That fear is understandable and it is exactly why so many left shift conversations stall.
But left shift is not about de-funding hospitals. It is about removing loss making activity so scarce capacity can be redeployed.
Done properly, left shift reduces inefficient turnover, releases constrained clinical time and allows trusts to protect and grow the activity they actually want.
The real prize lies in freeing up capacity for work that matters
When the right activity is shifted:
- Complex elective work becomes possible.
- RTT backlog recovery accelerates.
- Specialist pathways are protected.
- Clinician morale improves.
The NHS does not need industry to lecture it about transformation. It needs partners who understand what to take away, not just what to add.
This is where most industry offers miss the mark.
Industry’s mistake is treating left shift as a policy slogan
Many life science companies talk about left shift because it appears in national policy and ICS strategies and because it sounds progressive.
But few actually design offers that make left shift operationally safe. What the NHS worries about is not whether to shift but who carries the risk, who staffs the service, who holds governance and who picks up the bill when pilots end.
Left shift without infrastructure is just displacement and left shift with the wrong partner becomes another problem.
What NHS leaders actually want from left shift partners
Across ICBs, Trusts, Federations, Neighbourhoods, PCNs and provider collaboratives, the same unspoken conditions keep appearing.
NHS leaders want left shift that adds net capacity (not redistributes it), absorbs implementation risk, does not destabilise existing teams, fits real commissioning and contracting flows and can scale without heroics.
In short, they want left shift that works on a bad day, not just in a glossy pilot.
Left shift creates a very specific opportunity for pharma, medtech and device companies to enable this transformation practically.
That might mean:
- Funding and staffing transitional models.
- Supporting diagnostics and triage earlier in pathways.
- Delivering nurse led or community based services.
- Embedding digital monitoring to prevent deterioration.
- Redesigning pathways around flow, not products.
The product still matters, but it is no longer the lead actor. The lead role is played by capacity release.
A simple test for left shift credibility
Before positioning your offer as “left shift aligned”, ask yourself:
- Which hospital clinics does this reduce?
- Which clinician hours does this free up?
- Which backlog does this help unwind?
- Which part of the system breathes easier?
If the answer is vague, the NHS will spot it instantly. Left shift only lands when it solves a problem the system already feels.
Most trust leaders are all for left shift. What they are opposed to is unmanaged loss of income, erosion of workforce stability, fragmentation of pathways and pilots that leave them holding the risk.
When industry shows up with a coherent, capacity aware model, the tone of conversation changes dramatically because it feels safe.
From access conversations to partnership conversations
This is the pivot many companies need to make. There’s no sense in asking, “how do we get access for our product?”
The better question by far is, “where is this system congested, and how do we help unblock it?”
Access follows credibility. Credibility follows problem solving. And problem solving starts with capacity.
A challenge for Part 2
If Part 1 was about mindset, Part 2 is about intent. If your left shift narrative increases workload, shifts risk back to the NHS, depends on goodwill and heroics or collapses when industry funding ends, it will not scale.
But if your offer removes loss making activity, frees constrained clinical capacity, stabilises services under pressure and aligns with how the NHS actually works, you won’t need to chase access. You’ll be invited in.
In Part 3 of this blog series, I’ll go further into what “good” left shift actually looks like in practice, why some pilots scale and most don’t and how industry can design offers that survive NHS reality, not just policy ambition.
For now, remember this; left shift is not a slogan, it’s a capacity strategy. And capacity is the NHS problem that really matters right now.
At www.scottmckenzieconsultancy.com, I work directly inside the NHS, supporting provider collaboratives, commissioners and system leaders to implement real change. I then help pharma, medtech and device companies interpret what’s happening, so they can engage the right stakeholders, align with NHS priorities and get their innovations embedded into care pathways.
With more than 20 years working within the NHS and Pharma, medtech and devices companies, I bring a unique dual perspective, now captured in my book, Embedded: How Pharma, MedTech, and Device Companies Can Get Their Products into NHS Pathways and Stay There, which distils everything I’ve learned into a practical playbook. Whether you’re launching a new product or trying to unlock stalled adoption, Embedded shows you how to reframe your offer, align with NHS priorities and make change stick.
Tickets now on sale: The inaugural Embedded Seminar – London on September 30 – will bring together operational NHS leaders and senior industry teams to talk candidly about what actually lands in practice and what falls by the wayside. Speakers will include people running PCNs and federations, managing clinical risk in General Practice, integrating hospital and neighbourhood services and delivering system change under real constraints.